Investors might want to bet on Fresenius (FMS), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

Fistula monitoring system developer for dialysis patients PatenSee has signed a clinical collaboration agreement with Fresenius Medical Care. The companies will conduct a joint, multi-centre pilot ...

Berenberg Bank analyst Victoria Lambert maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) yesterday ...

Weirton Dialysis is facing significant challenges due to ongoing water situation in Weirton, making it difficult for it to ...

Learn more about whether Encompass Health Corporation or Fresenius Medical Care AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Marianne Bulot, an analyst from Bank of America Securities, reiterated the Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – ...

TSN, GM, FMS and DLX boast a low P/CF ratio. Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries.

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...